Close
Novotech
Jabsco PureFlo 21 Single Use

News

New Sanofi Vaccine 100 Percent Effective For Acute COVID

In the fight against COVID-19, the world may soon have another vaccine choice. A positive result from late-stage clinical testing of a novel vaccine that will be called Vidprevtyn has been announced by Sanofi and GSK by the formers...

Pancorona Virus Vaccine Soon A Reality- Dr. Drew Weissman

On the opening day of the 19th edition of BioAsia, a special fireside chat between Dr. Sangita Reddy, MD, of Apollo Hospitals and Dr. Drew Weissman, the pioneer who has brought mRNA tech to vaccines, spotlighted a revolutionary revelation...

What Comes After Compliance? Dr. Pranesh Srinivas on Smarter and Stronger Quality Systems

25th February 2022 - Trust isn’t just assumed in the life sciences; it’s built, tested, and validated. That professional approach has shaped Dr. Pranesh Sujaymeendra Davangere Srinivas’s journey from raising fruit flies in a makeshift lab to leading global...

Another Biomanufacturing Training Hub By WHO

WHO along with its academy and the Republic of Korea, have announced the inception of a global bio manufacturing training hub that will be of assistance to low and mid-income countries who are inclined to develop biologicals ranging from...

MNC Pharmaceutical Majors Revamping Operations In India

Earlier in February this year, Novartis, which happens to be a Swiss drug major, sold its three rooted brands to Dr Reddy’s Laboratories in India. If this wasn’t enough, they also went on to terminate 400 employees from positions,...

Swiss CDMO expands capsule filling capabilities

Contract development and manufacturing organisation (CDMO) Micro-Sphere has invested more than €1.5 million at its plant in Switzerland to expand its offering in encapsulation for inhalation products. Boosting its existing automatic capsule filling equipment Micro-Sphere has taken delivery of and...

To Enhance Biologics Dual Acquisition Done By Recipharm

Recipharm, the Swedish CDMO, which happens to be Moderna’s COVID-19 vaccine production partner, has undergone not one but two acquisitions in the week ending February 19th. This expansion is a part of a strategy that Recipharm has been eyeing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »